Bioverativ Inc. (BIVV) Is Too Rich For My Blood But Activist Jeff Ubben Likes It

Bioverativ Inc. (NASDAQ:BIVV) was spun off by Biogen (BIIB) about a month ago at a valuation of about $4.7 billion.

Keep Reading →